Kazia Therapeutics Annual Report 2021

2021 AT A GLANCE CHAIRMAN’S LETTER CEO’S REPORT KEY MILESTONES PIPELINE REVIEW PARTNER FOR SUCCESS WORK WITH THE BEST #2 IN THE KAZIA STORY FINANCIAL REPORTS Kazia Therapeutics Limited Annual Report 2021 73 KAZIA THERAPEUTICS LIMITED Corporate directory 30 June 2021 DIRECTORS Mr Iain Ross Mr Bryce Carmine Mr Steven Coffey Dr James Garner COMPANY SECRETARY Ms Kate Hill PRINCIPAL PLACE OF BUSINESS Three International Towers Level 24 300 Barangaroo Avenue Sydney, NSW 2000 SHARE REGISTER Computershare Investor Services Pty Limited Level 4 60 Carrington Street Sydney NSW 2000 Tel: 1300 787 272 AUDITOR Grant Thornton Audit Pty Ltd Level 17 383 Kent Street Sydney NSW 2000 STOCK EXCHANGE LISTING Kazia Therapeutics Limited ordinary shares are listed on the Australian Stock Exchange (ASX code: KZA) Kazia Therapeutics Limited’s ordinary shares trade in the United States in the form of ADRs on the NASDAQ Capital Market (NASDAQ code: KZIA). At year end each ADR represents ten ordinary Kazia shares. WEBSITE www.kaziatherapeutics.com ideate Co.